The management of primary mediastinal B-cell lymphoma with sclerosis.
Brugger
W
W
Albert-Ludwigs University Medical Center, Department of Hematology/Oncology, Freiburg, Germany.
Engelhardt
R
R
Mertelsmann
R
R
Kanz
L
L
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016393:Lymphoma, B-Cell / Q000473:pathology / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology / Q000628:therapy*; D008479:Mediastinal Neoplasms / Q000473:pathology / Q000628:therapy*; D011241:Prednisone / Q000008:administration & dosage; D012598:Sclerosis; D014750:Vincristine / Q000008:administration & dosage
D001761:Bleomycin; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone